Henoch-Schonlein Purpura (HSP)

What Is It, Signs and Symptoms, Treatment, and More

Author: Anna Hernández, MD
Editor: Alyssa Haag, MD
Editor: Józia McGowan, DO
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Illustrator: Jannat Day
Modified: Mar 04, 2025

What is Henoch-Shonlein purpura?

Henoch-Schonlein purpura (HSP), now known as immunoglobulin A (IgA) vasculitis, is a condition that causes damage to the body’s small blood vessels. It most commonly affects children under 10 years of age and its onset is typically preceded by a respiratory or gastrointestinal tract infection. Symptoms are generally mild and can include a palpable skin rash, colicky abdominal pain, and joint pain, as well as kidney problems. Fortunately, individuals usually recover spontaneously within a few months without treatment, although the condition can recur over time. 
An infographic detailing the background, signs and symptoms, diagnosis, and treatment of Henoch-Shonlein purpura.

What causes Henoch-Shonlein purpura?

Henoch-Schonlein purpura is a small blood vessel vasculitis caused by deposits of immunoglobulin A (IgA). IgA is the main antibody found in mucosal cells lining the respiratory, gastrointestinal, and genitourinary tract. In HSP, the levels of IgA are elevated and can aggregate with other proteins to form immune complexes. These immune complexes get deposited in small blood vessels throughout the body, particularly in the gastrointestinal system, skin, joints, and kidneys. The deposit of immune complexes causes activation of the immune system resulting in vascular inflammation and damage to the blood vessels. 

Typically, HSP presents in childhood and usually develops 1 to 3 weeks after a mucosal infection, such as a viral upper respiratory tract infection or a group A streptococcal pharyngeal infection. The infection triggers IgA antibody production, forming more immune complexes that can be deposited in the blood vessel walls. The exact reason why the IgA complexes form in the first place is unclear, but genetic factors are likely to play an important role. 

What are the signs and symptoms of Henoch-Shonlein purpura?

Henoch-Schonlein purpura is associated with a classic tetrad of symptoms, including palpable purpura (i.e., raised skin rash consisting of red to purple spots typically located on the buttocks and legs), abdominal pain, hematuria or bloody urine, and arthritis. In addition, individuals with Henoch-Schonlein purpura can present with general symptoms like fever, malaise, and fatigue. Specific signs and symptoms depend on where the IgA immune complexes are deposited.  

Joint pain most commonly presents in the knees and ankles, which can result in limping. If the IgA immune complexes get deposited in the blood vessels of the gastrointestinal tract, it can cause colicky abdominal pain, as well as nausea and vomiting. In rare cases, there can be gastrointestinal bleeding, which can present as hematochezia (i.e., blood in stool) or hematemesis (i.e., blood in emesis). Additionally, a hematoma in the intestinal wall could cause intussusception, a condition that occurs when part of the intestine folds into another section of the intestines, resulting in bowel obstruction 

In the kidneys, deposition of IgA immune complexes can lead to nephritic syndrome, which presents as blood in the urine, or hematuria. In some cases, the condition may progress to chronic kidney damage and even end-stage kidney failure. Less commonly, there may be other clinical manifestations, including inflammation of one or both testes (i.e., orchitis), as well as central nervous system involvement with headaches, behavioral changes, or seizures. 

How is Henoch-Shonlein purpura diagnosed?

Diagnosis of Henoch-Schonlein purpura is based on characteristic clinical features, including the presence of palpable purpura on the legs, along with acute abdominal painjoint pain, or kidney involvement. While the diagnosis is largely clinical, laboratory studies are generally performed to rule out other conditions and assess the severity of the disease. Blood tests may include a complete blood cell count (CBC) and coagulation panel, as well as electrolytes and renal function analysis. Urine tests may also be done to look for blood or proteins in the urine, which may indicate kidney damage. A skin biopsy is not necessary but may be useful to confirm the diagnosis in individuals with atypical symptoms. Regardless of the initial presentation, individuals may require follow-up assessments of kidney function to rule out worsening of kidney disease 

How is Henoch-Shonlein purpura treated?

Most individuals with Henoch-Schonlein purpura recover spontaneously over a few weeks without any treatment. Generally, management involves supportive measures, such as ensuring adequate hydration and giving pain-relief medications like oral acetaminophen. In cases of severe kidney involvement, immunosuppressive therapy with glucocorticoids or other medications (e.g., cyclosporine, rituximab) may be used to prevent the progression of kidney disease. While most individuals with Henoch-Schonlein purpura make a full recovery, the condition can sometimes recur months or years after, usually triggered by another infection.  

What are the most important facts to know about Henoch-Shonlein purpura?

Henoch-Schonlein purpura (HSP), now known as IgA vasculitis, is the most common vasculitis in childhood. It is caused by deposits of immune IgA complexes in the small blood vessels of the skin, gastrointestinal tract, joints, and kidneys. Affected individuals typically develop a palpable skin rashjoint pain, and abdominal pain 1 to 3 weeks after an upper respiratory tract infection. In some cases, there can be kidney involvement, most commonly presenting with blood in the urine. While the diagnosis is clinical, laboratory tests may be done to rule out other conditions and assess the severity of the disease. Generally, it is treated with glucocorticoids if the symptoms are severe, as most individuals recover spontaneously within a couple of months. 
Related topics

References


Reamy BV, Servey JT, Williams PM. Henoch-Schönlein purpura (IgA vasculitis): Rapid evidence review. Am Fam Physician. 2020;102(4):229-233. Accessed January 15, 2024. https://www.aafp.org/pubs/afp/issues/2020/0815/p229.pdf 


Park J, Berard RA, Grimmer J, Kirpalani A. IgA vasculitis: A review and update on the management of renal and extrarenal disease, highlighting what’s new for biomarkers and treatment. Curr Pediatr Rep. 2021;9(4):118-126. doi:10.1007/s40124-021-00247-8 


Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: An up-to-date review. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.771619 


Xu L, Li Y, Wu X. IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers. Front Immunol. 2022;13. doi:10.3389/fimmu.2022.921864